IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
Amendolara R, D'Onofrio L, Sessa RL, Di Giulio S, Mignogna C, Coraggio L, Schirano R, Zampetti S, Malandrucco I, Pozzilli P, Giannini G, Maddaloni E, Buzzetti R.
Amendolara R, et al. Among authors: di giulio s.
J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210/clinem/dgaf001. Online ahead of print.
J Clin Endocrinol Metab. 2025.
PMID: 39760686